Literature DB >> 24220699

A common variant at 8q24.21 is associated with renal cell cancer.

Julius Gudmundsson1, Patrick Sulem, Daniel F Gudbjartsson, Gisli Masson, Vigdis Petursdottir, Sverrir Hardarson, Sigurjon A Gudjonsson, Hrefna Johannsdottir, Hafdis Th Helgadottir, Simon N Stacey, Olafur Th Magnusson, Hannes Helgason, Angeles Panadero, Loes F van der Zanden, Katja K H Aben, Sita H Vermeulen, Egbert Oosterwijk, Augustine Kong, Jose I Mayordomo, Asgerdur Sverrisdottir, Eirikur Jonsson, Tomas Gudbjartsson, Gudmundur V Einarsson, Lambertus A Kiemeney, Unnur Thorsteinsdottir, Thorunn Rafnar, Kari Stefansson.   

Abstract

Renal cell carcinoma (RCC) represents between 80 and 90% of kidney cancers. Previous genome-wide association studies of RCC have identified five variants conferring risk of the disease. Here we report the results from a discovery RCC genome-wide association study and replication analysis, including a total of 2,411 patients and 71,497 controls. One variant, rs35252396[CG] located at 8q24.21, is significantly associated with RCC after combining discovery and replication results (OR=1.27, P(combined)=5.4 × 10(-11)) and has an average risk allele frequency in controls of 46%. rs35252396[CG] does not have any strongly correlated variants in the genome and is located within a region predicted to have regulatory functions in several cell lines, including six originating from the kidney. This is the first RCC variant reported at 8q24.21 and it is largely independent (r(2)≤0.02) of the numerous previously reported cancer risk variants at this locus.

Entities:  

Mesh:

Year:  2013        PMID: 24220699     DOI: 10.1038/ncomms3776

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  33 in total

Review 1.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

2.  Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes.

Authors:  Xiang Shu; Mark P Purdue; Yuanqing Ye; Huakang Tu; Christopher G Wood; Nizar M Tannir; Zhaoming Wang; Demetrius Albanes; Susan M Gapstur; Victoria L Stevens; Nathaniel Rothman; Stephen J Chanock; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-16       Impact factor: 4.254

Review 3.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

Review 4.  The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.

Authors:  Olga Lancho; Daniel Herranz
Journal:  Trends Cancer       Date:  2018-11-02

Review 5.  An emerging understanding of long noncoding RNAs in kidney cancer.

Authors:  Shuigen Zhou; Jiandong Wang; Zhengyu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-11       Impact factor: 4.553

6.  Variants on 8q24 and prostate cancer risk in Chinese population: a meta-analysis.

Authors:  Xiao-Qiang Ren; Jian-Guo Zhang; Shi-Yong Xin; Tao Cheng; Liang Li; Wei-Hua Ren
Journal:  Int J Clin Exp Med       Date:  2015-06-15

7.  The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians.

Authors:  Jennifer Jones; Jaimin Bhatt; Jonathan Avery; Andreas Laupacis; Katherine Cowan; Naveen Basappa; Joan Basiuk; Christina Canil; Sohaib Al-Asaaed; Daniel Heng; Lori Wood; Dawn Stacey; Christian Kollmannsberger; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2017-11-01       Impact factor: 1.862

8.  Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.

Authors:  Xiang Shu; Jianchun Gu; Maosheng Huang; Nizar M Tannir; Surena F Matin; Jose A Karam; Christopher G Wood; Xifeng Wu; Yuanqing Ye
Journal:  Carcinogenesis       Date:  2018-05-28       Impact factor: 4.944

Review 9.  Emerging applications of genome-editing technology to examine functionality of GWAS-associated variants for complex traits.

Authors:  Andrew J P Smith; Panos Deloukas; Patricia B Munroe
Journal:  Physiol Genomics       Date:  2018-04-13       Impact factor: 3.107

10.  SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155/HIF-1α signaling.

Authors:  Jiangyi Wang; Yun Zou; Bowen Du; Wenzhi Li; Guopeng Yu; Long Li; Lin Zhou; Xin Gu; Shangqing Song; Yushan Liu; Wenquan Zhou; Bin Xu; Zhong Wang
Journal:  Cell Death Dis       Date:  2021-07-03       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.